Clinical Trial: Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

Share this article:
Clinical Trial: Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

Sponsor and Collaborators

Grupo Espanol de Investigacion en Sarcomas

Contact
Contact: Xavier Garcia del Muro, MD
93 260 73 32
garciadelmuro@ico.scs.es

Principal Investigator
Study Director: Xavier Garcia del Muro, MD

ClinicalTrials.gov Identifier
NCT00541840
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs